Vir Biotechnology

$腾盛博药-B(02137)$ VIR的丁肝二期数据非常给力，三期在27年一季度出数据，大概率是可以上市的，这也为27年以后腾盛提供了一个现金流产品，保证公司活下去。。。。那时候，自身的乙肝三期数据也差不多快出来了 $Vir Biotechnology(VIR)$

#药闻简讯# $Vir Biotechnology(VIR)$ 授予Norgine在欧洲、澳大利亚和新西兰独家商业化慢性丁型肝炎候选疗法的许可，包括为正在进行的ECLIPSE临床开发项目提供全球成本分摊协议

$Vir Biotechnology(VIR)$ $Janux Therapeutics(JANX)$ 昨天我临阵脱逃了 虽然不多

$Vir Biotechnology(VIR)$ 有三个一期实体瘤dual-masked TCE（HER2 PSMA EGFR），还有一个三期丁型肝炎药物，值得关注。

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-019309  Size: 12 KB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-048624  Size: 5 KB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-019892  Size: 12 KB 网页链接

$Vir Biotechnology(VIR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001628280-25-049561  Act: 34  Size: 417 KB 网页链接

$Vir Biotechnology(VIR)$ 144 Report of proposed sale of securities Accession Number: 0001493152-25-025052  Act: 33  Size: 15 KB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-025571  Size: 12 KB 网页链接

美股生科IPO转暖的话 ，估计TCE领域里该有些公司出来融资了。$Vir Biotechnology(VIR)$ 这价格没啥好挑的。

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-025970  Size: 10 KB 网页链接

$Vir Biotechnology(VIR)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001628280-25-057394  Act: 34  Size: 293 KB 网页链接

$Vir Biotechnology(VIR)$ 144 Report of proposed sale of securities Accession Number: 0001959173-25-006744  Act: 33  Size: 5 KB 网页链接

$Vir Biotechnology(VIR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-25-049694  Act: 34  Size: 6 MB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-050592  Size: 4 KB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-049159  Size: 5 KB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-017612  Size: 12 KB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-043567  Size: 5 KB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-018462  Size: 12 KB 网页链接